JAKARTA - Indonesian scientists are set to start the phase III clinical trials of a potential Covid-19 vaccine developed by China-based biopharmaceutical company Sinovac Biotech on Tuesday in six different locations in the West Java provincial capital of Bandung.
The six locations chosen for the trials are the Unpad Pendidikan Hospital, an Unpad campus, as well as four community health centres in Bandung, namely Sukapakir, Garuda, Ciumbuleuit and Dago.Kusnandi said half of the 1,620 volunteers would be injected with the potential vaccine, while the other half would get a placebo.After the first injection, Kusnandi said, the volunteers would be observed for 30 to 40 minutes to find out if they showed any reactions to the vaccine.
State-owned pharmaceutical holding company PT Bio Farma president director Honesti Basyir said the company was currently conducting a stability test on the vaccine in its laboratory facilities. He said Bio Farma would increase its production capacity and be ready to produce 250 million doses of the Sinovac vaccine per year by December.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »